K. Watanabe

发表

Response to combined modality treatment in a five-year survivor of extensive small cell lung cancer with severe complications.

H. Kunikane, H. Okamoto, A. Nagatomo, 2000, Internal medicine.

Phase II trial of docetaxel in previously untreated advanced non-small-cell lung cancer: a Japanese cooperative study.

T. Taguchi, H. Niitani, K. Furuse, 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Phase II study of 3-hour infusion of paclitaxel in previously untreated non-small cell lung cancer.

N. Saijo, Y. Nishiwaki, S. Yoneda, 1996, Clinical cancer research : an official journal of the American Association for Cancer Research.

Efficacy of recombinant human granulocyte-macrophage colony-stimulating factor for chemotherapy-induced leukopenia in patients with non-small-cell lung cancer

K. Eguchi, N. Saijo, K. Nakada, 2004, Cancer Chemotherapy and Pharmacology.

A study of dose escalation of teniposide (VM-26) plus cisplatin (CDDP) with recombinant human granulocyte colony-stimulating factor (rhG-CSF) in patients with advanced small cell lung cancer.

K. Eguchi, N. Saijo, Y. Ohe, 1994, European journal of cancer.

Phase I/II and pharmacologic study of long-term continuous infusion etoposide combined with cisplatin in patients with advanced non-small-cell lung cancer.

H. Kunitoh, K. Watanabe, K. Watanabe, 1994, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

A phase II trial of dose-dense chemotherapy, followed by surgical resection and/or thoracic radiotherapy, in locally advanced thymoma: report of a Japan Clinical Oncology Group trial (JCOG 9606)

N. Saijo, Y. Nishiwaki, T. Tamura, 2010, British Journal of Cancer.

Phase III study of intensive weekly chemotherapy with recombinant human granulocyte colony-stimulating factor versus standard chemotherapy in extensive-disease small-cell lung cancer. The Japan Clinical Oncology Group.

N. Saijo, Y. Nishiwaki, M. Fukuoka, 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Phase II study of area under the plasma-concentration-versus-time curve-based carboplatin plus standard-dose intravenous etoposide in elderly patients with small-cell lung cancer.

K. Mori, N. Saijo, Y. Nishiwaki, 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Randomised phase III trial of carboplatin plus etoposide vs split doses of cisplatin plus etoposide in elderly or poor-risk patients with extensive disease small-cell lung cancer: JCOG 9702

N. Saijo, S. Kudoh, H. Kunikane, 2007, British Journal of Cancer.

A phase II study of trastuzumab monotherapy in pretreated patients with non-small cell lung cancers (NSCLCs) harboring HER2 alterations: HOT1303-B trial.

H. Dosaka-akita, T. Harada, S. Oizumi, 2018, Annals of oncology : official journal of the European Society for Medical Oncology.

Double-blind randomized control trial of the effect of recombinant human erythropoietin on chemotherapy-induced anemia in patients with non-small cell lung cancer

N. Saijo, M. Fukuoka, H. Kunikane, 2001, International Journal of Clinical Oncology.

Phase I/II Pharmacokinetic and Pharmacogenomic Study of UGT1A1 Polymorphism in Elderly Patients With Advanced Non–Small Cell Lung Cancer Treated With Irinotecan

M. Shibuya, K. Eguchi, H. Kunikane, 2009, Clinical pharmacology and therapeutics.

Concurrent daily carboplatin and accelerated hyperfractionated thoracic radiotherapy in locally advanced nonsmall cell lung cancer.

H. Kunitoh, H. Okamoto, A. Nagatomo, 1997, International journal of radiation oncology, biology, physics.

Phase II study of docetaxel and cisplatin in patients with previously untreated metastatic non-small-cell lung cancer

Y. Ichinose, H. Niitani, Y. Segawa, 2000, International Journal of Clinical Oncology.

A combination chemotherapy of carboplatin and irinotecan in elderly patients with small cell lung cancer (SCLC).

H. Kunikane, H. Okamoto, A. Nagatomo, 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Phase I study of docetaxel and cisplatin for patients with previously untreated metastatic non-small-cell lung cancer: a Japanese cooperative study

K. Tominaga, H. Niitani, M. Yamakido, 2000, International Journal of Clinical Oncology.

Clinical Application of Radiolabeled Human X Human Monoclonal Antibody with Interferon in the Treatment of Malignant Glioma—Preliminary Report

K. Ichikawa, M. Nagai, K. Watanabe, 1991 .

A phase I study of binimetinib (MEK162) in Japanese patients with advanced solid tumors

Y. Ando, Y. Hirashima, T. Shibata, 2016, Cancer Chemotherapy and Pharmacology.

[A case of pulmonary cavernous hemangioma: immunohistological examination revealed its endothelial cell origin].

H. Kunikane, H. Okamoto, K. Sakamoto, 2000, Kyobu geka. The Japanese journal of thoracic surgery.

Combination Chemotherapy Using Carboplatin (JM-8) and Etoposide (JET Therapy) for Recurrent Malignant Gliomas: A Phase II Study

Y. Fujiyama, K. Watanabe, P. Kim, 2002, Acta Neurochirurgica.

Prospective study of mutant frequencies at the hprt and T-cell receptor gene loci in pediatric cancer patients during chemotherapy.

K. Furusho, M. Kubota, Y. Akiyama, 1998, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

Evaluation of mutant frequencies at the hprt and the T-cell receptor loci in pediatric cancer patients before treatment.

K. Furusho, M. Kubota, Y. Akiyama, 1998, Mutation research.

A phase II study of cisplatin and docetaxel administered as three consecutive weekly infusions for advanced non-small-cell lung cancer in elderly patients.

H. Ohmatsu, R. Kakinuma, N. Saijo, 2004, Annals of oncology : official journal of the European Society for Medical Oncology.

Feasibility trial for adjuvant chemotherapy with docetaxel plus cisplatin followed by single agent long-term administration of S-1 chemotherapy in patients with completely resected non-small cell lung cancer: Thoracic Oncology Research Group Study 0809

M. Tsuboi, Y. Hosomi, N. Ikeda, 2013, British Journal of Cancer.

A study of the combination of gemcitabine hydrochloride (LY188011) and cisplatin in non-small-cell lung cancer: 3-week schedule

H. Niitani, H. Kunikane, Y. Fujita, 2001, International Journal of Clinical Oncology.

Legionnaires' disease diagnosed by bronchoalveolar lavage.

H. Kunikane, H. Okamoto, A. Nagatomo, 1998, Internal medicine.

A double-blind, placebo-controlled trial of the thromboxane synthetase blocker OKY-046 on bronchial hypersensitivity in bronchial asthma patients.

H. Kunitoh, H. Okamoto, A. Nagatomo, 1998, The Journal of asthma : official journal of the Association for the Care of Asthma.

A randomized phase-II study of BB-10010 (macrophage inflammatory protein- 1alpha) in patients with advanced breast cancer receiving 5-fluorouracil, adriamycin, and cyclophosphamide chemotherapy.

A. Howell, H. Earl, D. Miles, 1998, Blood.